- Home
- CGC vs TVGN Comparison
CGC vs TVGN Comparison
Compare CGC & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGC
- TVGN
- Stock Information
- Founded
- CGC N/A
- TVGN 2020
- Country
- CGC Canada
- TVGN United States
- Employees
- CGC N/A
- TVGN N/A
- Industry
- CGC Pharmaceuticals and Biotechnology
- TVGN Blank Checks
- Sector
- CGC Health Care
- TVGN Finance
- Exchange
- CGC Nasdaq
- TVGN Nasdaq
- Market Cap
- CGC 239.2M
- TVGN 193.1M
- IPO Year
- CGC N/A
- TVGN N/A
- Fundamental
- Price
- CGC $1.14
- TVGN $1.06
- Analyst Decision
- CGC Hold
- TVGN Strong Buy
- Analyst Count
- CGC 1
- TVGN 1
- Target Price
- CGC N/A
- TVGN $10.00
- AVG Volume (30 Days)
- CGC 10.1M
- TVGN 645.6K
- Earning Date
- CGC 08-08-2025
- TVGN 08-13-2025
- Dividend Yield
- CGC N/A
- TVGN N/A
- EPS Growth
- CGC N/A
- TVGN N/A
- EPS
- CGC N/A
- TVGN N/A
- Revenue
- CGC $187,146,485.00
- TVGN N/A
- Revenue This Year
- CGC $11.99
- TVGN N/A
- Revenue Next Year
- CGC $6.84
- TVGN N/A
- P/E Ratio
- CGC N/A
- TVGN N/A
- Revenue Growth
- CGC N/A
- TVGN N/A
- 52 Week Low
- CGC $0.77
- TVGN $0.26
- 52 Week High
- CGC $8.04
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- CGC 45.22
- TVGN 36.03
- Support Level
- CGC $1.08
- TVGN $1.18
- Resistance Level
- CGC $1.27
- TVGN $1.42
- Average True Range (ATR)
- CGC 0.08
- TVGN 0.07
- MACD
- CGC 0.01
- TVGN -0.02
- Stochastic Oscillator
- CGC 26.92
- TVGN 5.26
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.